| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 09/14/2005 | EP1572645A2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 09/14/2005 | EP1572197A1 4- 1- (sulfonyl) -1h-indol-2-yl)-4- (hydroxy) -cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents |
| 09/14/2005 | EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 09/14/2005 | EP1071420B1 Indolyl-3-glyoxylic acid derivatives with antitumoral activity |
| 09/14/2005 | CN1668721A Immunoadhesin comprising a glycoprotein VI domain |
| 09/14/2005 | CN1668709A Polymerisable diketopyrrolopyrroles, use of such compounds in colour filters and polymers prepared from these compounds |
| 09/14/2005 | CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 09/14/2005 | CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 09/14/2005 | CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives |
| 09/14/2005 | CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives |
| 09/14/2005 | CN1668595A Method of forming a carbon-carbon or carbon-heteroatom linkage |
| 09/14/2005 | CN1668591A Phenol derivatives and method of use thereof |
| 09/14/2005 | CN1668590A 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/14/2005 | CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 09/14/2005 | CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/14/2005 | CN1668587A Indole derivatives and drugs containing the same |
| 09/14/2005 | CN1668586A Method for preparing 13 5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal |
| 09/14/2005 | CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 09/14/2005 | CN1668298A Antitumor compound and therapeutic uses thereof |
| 09/14/2005 | CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 09/14/2005 | CN1668291A Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 09/14/2005 | CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/14/2005 | CN1218919C Fluorene derivatives and their application |
| 09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
| 09/13/2005 | US6943174 6,5-Fused bicyclic heterocycles |
| 09/13/2005 | CA2179634C 4-arylisoindole analgesics |
| 09/09/2005 | WO2005082882A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 09/09/2005 | WO2005082851A2 Charge transport compounds and electronic devices made with such compounds |
| 09/09/2005 | WO2005082850A1 Process for producing monatin |
| 09/09/2005 | WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof |
| 09/09/2005 | WO2005058819A8 Polymorphic forms of tegaserod base and salts thereof |
| 09/09/2005 | WO2005014584A8 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 09/09/2005 | CA2556830A1 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber |
| 09/09/2005 | CA2554439A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 09/08/2005 | US20050197501 Reacting calcium hydroxide with an ester derivative or protected ester derivative of the statin; rosuvastatin, pitavastatin and atorvastatin, simvastatin and lovastatin |
| 09/08/2005 | US20050197383 Quaternary ammonium compounds and their use as anti-tussive agents |
| 09/08/2005 | US20050197382 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 09/08/2005 | US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 09/08/2005 | US20050197373 Substituted fused bicyclic amines as modulators of chemokine receptor activity |
| 09/08/2005 | US20050197362 Preventives/remedies for urinary disturbance |
| 09/08/2005 | US20050197343 N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide or 2-ferrocenyl compounds; psychiatric diseases: schizophrenia , unipolar depression, disturbances of consciousness, antidepressant; neurodegenerative diseases: Parkinson's disease, attention deficit hyperactivity syndrome; drug abuse |
| 09/08/2005 | US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/08/2005 | US20050197301 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 09/08/2005 | US20050197299 Peptidomimetic protease inhibitors |
| 09/08/2005 | DE102004006785A1 Verfahren zur CC-Bindungsknüpfung zwischen elektrophilen Substraten und TT-Verbindungen in neutralen bis basischen wässrigen oder alkoholischen Lösungsmitteln ohne den Einsatz einer Lewis- oder Protonensäure Process for carbon-carbon bond between electrophilic substrates and TT compounds in neutral to basic aqueous or alcoholic solvents without the use of a Lewis or protic acid |
| 09/07/2005 | EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/07/2005 | EP1569916A1 Substituted aralkyl derivatives |
| 09/07/2005 | EP1569911A1 Indazole derivatives as crf antagonists |
| 09/07/2005 | EP1569904A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 09/07/2005 | EP1569903A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 09/07/2005 | EP1569902A1 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 09/07/2005 | EP1569901A2 ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) |
| 09/07/2005 | EP1569900A2 Substituted 3-carbonyl-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 09/07/2005 | EP1569899A2 SUBSTITUTED 3-ALKYL AND 3-ARYLALKYL i 1H /i -INDOL-1-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) |
| 09/07/2005 | EP1569639A2 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 09/07/2005 | EP1569638A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 09/07/2005 | EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 09/07/2005 | EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists |
| 09/07/2005 | EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors |
| 09/07/2005 | EP1192132B1 Serine protease inhibitors |
| 09/07/2005 | EP1188747B1 Phenoxypropylamine compounds |
| 09/07/2005 | EP1178794B1 Use of succinic acid derivatives to obtain a medicine for treating inflammation |
| 09/07/2005 | CN1666577A Electronic devices made with electron transport and/or anti-quenching layers |
| 09/07/2005 | CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions |
| 09/07/2005 | CN1665850A Heterocyclic nitrogen-containing activators and catalyst systems for olefin polymerization |
| 09/07/2005 | CN1665849A Halogen substituted catalyst system for olefin polymerization |
| 09/07/2005 | CN1665823A Process for preparing 1, 2, 3, 9-tetrahydro-9-methyl-3-[2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
| 09/07/2005 | CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same |
| 09/07/2005 | CN1665809A Azaindoles |
| 09/07/2005 | CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases |
| 09/07/2005 | CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same |
| 09/07/2005 | CN1217932C Antibacterial agents |
| 09/07/2005 | CN1217931C Spirocyclic phenyl keto-enols as pesticides and herbicides |
| 09/07/2005 | CN1217930C Process for preparation of indole derivatives and intermediates of the process |
| 09/07/2005 | CN1217922C 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/06/2005 | US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine, |
| 09/06/2005 | US6939890 Antiinflammatory agents; sepsis shock; rheumatic disorders |
| 09/06/2005 | US6939889 Quarternary ammonium compounds |
| 09/06/2005 | US6939888 Heterocyclic amides such as 3-(2-chloro-6-methoxyphenyl)-5-isopropyl-5-methyl-4-acetoxy-3-pyrrolidine-2 -one, used as insecticides or miticides |
| 09/06/2005 | US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 09/06/2005 | US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders |
| 09/06/2005 | US6939869 Pyrrolo[2,1-c][1,4] benzodiazepine-indole derivatives, their preparation process, and uses of the same |
| 09/06/2005 | US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
| 09/06/2005 | US6939515 Apparatuses and methods for creating and testing pre-formulations and systems for same |
| 09/01/2005 | WO2005080361A1 Histamine-3 receptor modulators |
| 09/01/2005 | WO2005080337A1 Oxime ester compound, photopolymerizable composition and color filter utilizing the same |
| 09/01/2005 | WO2005080336A1 Novel benzofurans and indols |
| 09/01/2005 | WO2005080335A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
| 09/01/2005 | WO2005080333A1 Process for purification of ropinirole |
| 09/01/2005 | WO2005080332A1 Novel form of fluvastatin sodium |
| 09/01/2005 | WO2005080331A1 Fluorescent probe |
| 09/01/2005 | WO2005080330A1 Heteroarylphenylurea derivative |
| 09/01/2005 | WO2005080329A2 Process for manufacture of racemic carvedilol |
| 09/01/2005 | WO2005080322A1 Fluorene derivative |
| 09/01/2005 | WO2005080317A2 Therapeutic amide derivatives |
| 09/01/2005 | WO2005079497A2 Substituted fused bicyclic amines as modulators of chemokine receptor activity |
| 09/01/2005 | WO2005079496A2 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
| 09/01/2005 | WO2003101941A3 Alpha acyloxyacetamides for kallikrein and urokinase inhibition |